Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neuropathy Treatment Group is a private U.S. consumer health company focused on direct-to-consumer products for peripheral nerve health and neuropathy-related symptoms. The business appears to operate primarily through branded supplement products, especially Nerve Renew, and has also been associated with the Life Renew and Nerve Health Group names. Available public information suggests the company markets proprietary oral formulations positioned for nerve support, discomfort relief, and related wellness claims rather than developing prescription therapeutics. It is not a traditional biotech or pharma developer with a disclosed clinical-stage drug pipeline; instead, it appears to be a commercial-stage healthcare products business centered on nutraceuticals and e-commerce.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuropathy Treatment Group.